Triadic balance and network evolution in predictive models of signed networks.

This paper introduces a novel approach for identifying dynamic triadic transformation processes, applied to five networks: three undirected and two directed. Our method significantly enhances the prediction accuracy of network ties. While balance theory offers insights into evolving patterns of triadic structures, its effects on overall network dynamics remain underexplored.

A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection.

Background: Epstein-Barr virus (EBV) is a significant global public health concern because of its association with various malignancies and autoimmune diseases. Over 90% of the global population is chronically infected with EBV, impacting numerous cancer-related cases annually. However, none of the effective prophylactic vaccines against EBV is approved at present.

Identification of biomarkers for chronic renal fibrosis and their relationship with immune infiltration and cell death.

Background: Chronic kidney disease (CKD) represents a significant global public health challenge. This study aims to identify biomarkers of renal fibrosis and elucidate the relationship between unilateral ureteral obstruction (UUO), immune infiltration, and cell death.

Methods: Gene expression matrices for UUO were retrieved from the gene expression omnibus (GSE36496, GSE79443, GSE217650, and GSE217654).

Polar vortex hidden in twisted bilayers of paraelectric SrTiO.

Polar topologies, such as vortex and skyrmion, have attracted significant interest due to their unique physical properties and promising applications in high-density memory devices. To date, all known polar vortices are present in or induced by ferroelectric materials. In this study, we find polar vortex arrays in paraelectric SrTiO.

[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China].

To observe and evaluate the clinical efficacy and safety of albumin-bound paclitaxel as first-line treatment for patients with advanced pancreatic cancer in China, and to explore the prognosis-related molecules in pancreatic cancer based on next-generation sequencing (NGS) of tumor tissues. From December 2018 to December 2020, patients with locally advanced or metastatic pancreatic cancer were recruited to accept albumin-bound paclitaxel as first-line treatment in the oncology departments of 24 hospitals in East China. The primary endpoints were overall survival (OS) and treatment related adverse events, and the secondary endpoint was progression-free survival (PFS).